|
 |
|||||||
 |
PRESS RELEASES ADVENTRX Pharmaceuticals to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference SAN DIEGO – October 22, 2004 – ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX) announced today that it will present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference. Evan M. Levine, President and CEO, will give an update on the CoFactor™ clinical trial and present a corporate overview. The presentation is scheduled for Tuesday, October 26 at 8:40am (EDT) at the Waldorf Astoria hotel in New York City. About ADVENTRX ADVENTRX Pharmaceuticals, Inc. is a biopharmaceutical research and development company whose business strategy is to commercialize leading edge medical research through licensing agreements with prominent universities and research institutions. The Company focuses on cancer and viral research to launch products that either extend the usefulness of current therapies or replace marginal therapies with new approaches to treatment. More information can be found on the Company's website at www.adventrx.com. This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are made based on management's current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors, including uncertainties inherent in the drug development process, the timing and success of clinical trials, the validity of research results, and the receipt of necessary approvals from the United States Food and Drug Administration. The Company undertakes no obligation to release publicly any revisions, which may be made to reflect events or circumstances after the date hereof. Contact: Andrea Lynn ADVENTRX Pharmaceuticals 858 552-0866 |
